Febuxostat Tablets

Solicitation SPE2D2-26-R-0012 is a requirements contract issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the procurement of Febuxostat tablets. The scope includes Febuxostat 40mg tablets in 30-count bottles, with an estimated base year quantity of 76,388 bottles, as well as Febuxostat 80mg tablets in 30-count bottles. Award will be granted to the responsible offeror who is determined to be technically acceptable and provides the lowest evaluated aggregate price. Technical acceptability is based on compliance with the Statement of Work and a review of relevant past performance from the three years prior to solicitation. The contract mandates strict adherence to FDA current Good Manufacturing Practices and requires products to have an FDA Therapeutic Equivalence Code of A. Packaging must feature child-proof closures, a minimum bottle volume of 100cc, and specific cylindrical dimensions to ensure compatibility with automated dispensing units. Detailed bar-coding requirements are enforced at the unit-of-use level, utilizing GS1-128, GS1 DataBar, or UPC symbologies. Offerors must submit their proposals exclusively through the DIBBS portal, with the final closing date for receipt of offers extended to October 15, 2026, at 3:00 PM EST.